Provider
Coagulation Factor VIIa - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2025
Search Results
Displaying 2121 - 2130 of 3795 results
Provider
P73-21 Update to Reimbursement Policy Lab Path Services - 002 Professional Component for Pathology Test
Program effective Date: Nov 01, 2021
Provider
P74-21 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Program effective Date: Nov 01, 2021
Provider
2021 November Bulletins
Program effective Date: Nov 01, 2021
Provider
Neurotrophic Keratitis - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2024
Provider
P67-21 Medical Drug Policy Update – Infliximab Preferred Product Expansion to Include Remicade, Inflectra, and Renflexis
Program effective Date: Nov 01, 2021
Provider
P68-21 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: Nov 01, 2021
Provider
Hemophilia Factor IX - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2024
Provider
Gattex (teduglutide) - Commercial
Prior Authorization
Program effective Date: Nov 01, 2024